Matt Abernethy Neurocrine Biosciences Inc (NBIX) insider trading activity

NBIX Quotes by TradingView

Matt Abernethy is Chief Financial Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 35,810 shares of NBIX, which is worth approximately $4.25 Million. The most recent transaction as insider was on Dec 01, 2021, when has been sold 1,645 shares (Common Stock) at a price of $82.59 per share, resulting in proceeds of $135,861. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.8K
13.58% 3M change
13.58% 12M change
Total Value Held $4.25 Million

MATT ABERNETHY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2021
SELL
Open market or private sale
$135,861 $82.59 p/Share
1,645 Reduced 9.14%
16,349 Common Stock
Feb 08 2021
SELL
Open market or private sale
$339,975 $116.83 p/Share
2,910 Reduced 16.37%
14,869 Common Stock
Dec 01 2020
SELL
Open market or private sale
$155,716 $94.66 p/Share
1,645 Reduced 12.52%
11,494 Common Stock
Nov 12 2020
SELL
Open market or private sale
$204,800 $90.74 p/Share
2,257 Reduced 18.39%
10,014 Common Stock
MA

Matt Abernethy

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBIX